Journal
MEDICAL MYCOLOGY
Volume 54, Issue 7, Pages 699-713Publisher
OXFORD UNIV PRESS
DOI: 10.1093/mmy/myw025
Keywords
Parengyodontium; Parengyodontium album; Engyodontium album; cutaneous hyalohyphomycosis; cryptic species; Cordycipitaceae
Categories
Funding
- Strategic Research Theme Fund
- Mary Sun Medical Scholarship
- Wong Ching Yee Medical Postgraduate Scholarship
- University Postgraduate Scholarship
- University of Hong Kong, Hong Kong
- Croucher Senior Medical Research Fellowship, Croucher Foundation, Hong Kong
Ask authors/readers for more resources
Engyodontium album is an environmental saprobic mould and an emerging opportunistic pathogen able to cause both superficial and systemic infections. In this study, we isolated a mould from the skin lesion biopsy specimen of the right shin in a patient who received renal transplantation for end-stage renal failure with prednisolone, tacrolimus, and azathioprine immunosuppressant therapy. Histology of the skin biopsy showed mild squamous hyperplasia and neutrophilic infiltrate in the epidermis, active chronic inflammation in the dermis, and fat necrosis in the subcutis, with numerous fungal elements within the serum crusts. On Sabouraud glucose agar, the fungus grew as white, cobweb-like, floccose colonies. Microscopically, conidiogenous cells were arranged in whorls of one to seven at wide angles, with zigzag-shaped terminal fertile regions and smooth, hyaline, oval, apiculate conidia. DNA sequencing showed the mould isolate belonged to E. album but matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-TOF MS) failed to identify the isolate. Phylogenetic analyses based on the internal transcribed spacer region, 28S nuclear ribosomal DNA, and beta-tubulin gene and MALDI-TOF MS coupled with hierarchical cluster analysis showed that E. album is distantly related to other Engyodontium species and should be transferred to a novel genus within the family Cordycipitaceae, for which the name Parengyodontium album gen. et comb. nov. is proposed. Three potential cryptic species within this species complex were also revealed. Antifungal susceptibility testing showed posaconazole and voriconazole had high activities against all clinical P. album isolates and may be better drug options for treating P. album infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available